Litigation Details for In re: Auryxia (Ferric Citrate) Patent Litigation (D. Del. 2019)
✉ Email this page to a colleague
In re: Auryxia (Ferric Citrate) Patent Litigation (D. Del. 2019)
| Docket | ⤷ Subscribe | Date Filed | 2019-07-31 |
| Court | District Court, D. Delaware | Date Terminated | 2021-11-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 10,300,039; 7,767,851; 8,093,423; 8,299,298; 8,338,642; 8,609,896; 8,754,257; 8,754,258; 8,846,976; 8,901,349; 9,050,316; 9,328,133; 9,387,191; 9,757,416 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In re: Auryxia (Ferric Citrate) Patent Litigation
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for In re: Auryxia (Ferric Citrate) Patent Litigation (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-08-26 | 16 | Complaint - Amended | the “’416 patent”); 9,387,191 (the “’191 patent”); and 10,300,039 (the “’039 patent”) (collectively, … United States Patent Nos. 5,753,706 (the “’706 patent”); 7,767,851 (the “’851 patent”); 8,093,423 (the…(the “’423 patent”); 8,299,298 (the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896…’896 patent”); 8,754,257 (the “’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent…,349 (the “’349 patent”); 9,050,316 (the “’316 patent”); 9,328,133 (the “’133 patent”); 9,757,416 (the | External link to document |
| 2020-07-29 | 168 | Notice of Service | Preliminary Invalidity Contentions as to U.S. Patent No. 10,300,039 filed by Chemo Research S.L., Insud Pharma… In re: Auryxia (Ferric Citrate) Patent Litigation 31 July 2019 15 November…November 2021 1:19-md-02896 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
